#324 Genetic Contraindications for Ozempic and Wegovy (GLP-1 Agonists)
17 Jan 2025
• EN
Dr. Josiah Allen explains how genetic mutations (like RET) influence the safety of GLP-1 agonists like Ozempic and Wegovy.
From "DNA Today: A Genetics Podcast"
Listen on your iPhone
Download our iOS app and listen to interviews anywhere. Enjoy all of the listener functions in one slick package. Why not give it a try?
Comments
Add comment Feedback